SCHEMBL16295671

SCHEMBL16295671

[CH2]N(C)c1ncco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4722845 0.80
SCHEMBL4764157 0.73
SCHEMBL6591160 0.71
SCHEMBL6641400 0.71
SCHEMBL11967752 0.70 ELANE (0.38)
SCHEMBL4724154 0.70 HCAR3 (0.37)
SCHEMBL4721756 0.70 GBA1 (0.35)
SCHEMBL4723841 0.67 HRH3 (0.36)
SCHEMBL4724016 0.67 HCAR3 (0.35)
SCHEMBL21938419 0.66 MLYCD (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431418-B Metalloenzyme Inhibitor Compounds 北卡罗来纳维亚梅特制药公司 2019-02-05 CN disclosed
US-9688671-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2017-06-27 US disclosed
US-20160130263-A1 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS, INC. (US) 2016-05-12 US disclosed
EP-3008051-A1 METALLOENZYME INHIBITOR COMPOUNDS Viamet Pharmaceuticals, Inc. (US) 2016-04-20 EP disclosed
WO-2014201161-A1 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS, INC. (US) 2014-12-18 WO disclosed